Lesaka Technologies Q4 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $82.000M
Lesaka Technologies (NASDAQ:LSAK) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.04 by 25 percent. This is a 150 percent increase over earnings of $0.02 per share from the
China’s Geely Snaps Profit-Decline Streak, Raises Sales View For 2023
Geely Automobile Holdings Ltd (OTCPK: GELYY) (OTCPK: GELYF) on Tuesday reported yearly earnings, snapping four consecutive years of…
Lennar Shares In Building Mode: Behind The Earnings Beat And Rising Homebuilder Confidence
Lennar Corp (NYSE: LEN) shares are on the rise as the homebuilder's earnings outperformed expectations on both revenue and earnings per share. While this may be one factor driving the stock price, another catalyst could be the uptick in a separate homebuilder confidence indicator.
The AI ‘OG’ Just Blew Out It’s Financial Results — And Shares Are On A Tear
The overarching stock story of 2023 — while still early into the year — has been focused on artificial intelligence, namely OpenAI’s sophisticated chatbot ChatGPT.
UpHealth Expects FY2023 Revenues Of $127M-$135M Vs. $177.85M Estimate
This represents growth of 5% to 12% over pro forma 2022 revenue of $121 million. For comparison purposes, both the 2023 estimated revenue and 2022 pro forma revenue include five months of
Why NeoGenomics Shares Are Trading Higher Today
NeoGenomics Inc (NASDAQ:NEO) reported Q4 revenues of $138.71 million, +10.3% Y/Y beating the consensus of $129.97 million but aligned with…
Analysts Weigh In On Applied Materials Earnings Print: What Investors Need To Know
Semiconductor equipment provider Applied Materials, Inc (NASDAQ: AMAT) beat the Street's expectations for its fiscal first quarter.
The Santa Clara, California-based company issued upbeat guidance for the current quarter. As a result, several prominent analysts issued notes on the stock.
Analyst Views West Pharmaceutical’s Q4 Earnings Impressive Despite Headwinds
West Pharmaceutical Services Inc (NYSE:WST) reported Q4 2022 net sales of $708.7 million, down 3%, and organic net sales growth…